Full Text (PDF)
Review Article

Nanomedicine and Immune Response

Ramendra Pati Pandey, Suresh Kumar

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


RFP Indian Journal of Hospital Infection 1(1):p 47-49, January-June 2024. | DOI: NO

How Cite This Article:


Timeline

Received : January 12, 2024         Accepted : March 20, 2024          Published : June 21, 2024

Abstract

Nanoparticles are promising area of research in the area of drug delivery system. Immunostimulation or Immunosuppression properties are imporatnt to taking into consideration during the preparation of nanoparticles. Nanoparticles drug delivery system mediated immunostimulation and immunosuppression is crucial to make effective delivery systems. Nanomedicine is promising to use for diagnosis and relatively new therapeutics of infectious diseases.


References

  • 1.   Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol. 2010 Aug; 11(8):647- 55. doi: 10.1038/ni.1894. Review. PubMed PMID: 20644570.
  • 2.   Ishii KJ, Uematsu S, Akira S. ‘Toll’ gates for future immunotherapy. Curr Pharm Des. 2006; 12(32):4135-42. Review. PubMed PMID: 17100616.
  • 3.   Makkouk A, Abdelnoor AM. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents. Immunopharmacol Immunotoxicol. 2009; 31(3):331-8. doi: 10.1080/08923970902802926. Review.
  • 4.   Chanchal, Abhishek; Vohra, Richa; Elesela, Srikanth; Bhushan, Lokesh; Kumar, Santosh; Kumar, Suresh; Ahmad, Saheem; Pandey, Ramendra Pati. Gelatin Biopolymer: A Journey from Micro to Nano. Journal of Pharmacy Research 2014; 8(10).
  • 5.   Ramendra Pati Pandey, Abhishek Chanchal, Richa Vohra, Md. Najmul Islam, Santosh Kumar, Lokesh Bhushan, Suresh Kumar, Pawan Sharma. Immune Response of Biopolymeric nanoparticulate systems. Journal of Pharma Research 2015; 4(8).

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
January 12, 2024 March 20, 2024 June 21, 2024

DOI: NO

Keywords


Article Level Metrics

Last Updated

Monday 22 June 2026, 07:40:47 (IST)


374

Accesses

0
105
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received January 12, 2024
Accepted March 20, 2024
Published June 21, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share